BiotechTube
Home/Bryn Pharma/David Dworaczyk, Ph.D.
DD

David Dworaczyk, Ph.D.

Co-founder, President & CEO

Bryn Pharma

Therapeutic Areas

Allergy & Immunology

Bryn Pharma Pipeline

DrugIndicationPhase
UTULY™Treatment of severe allergic reactions (Type I), including anaphylaxisPhase 3

Leadership Team at Bryn Pharma

RL
Richard Lowenthal
Co-founder
View full Bryn Pharma profile